Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer
RCC patients with an abundance of tumor-specific cytotoxic T lymphocytes (CTLs) and increased immunogenicity of tumor cells in the TME may be better candidates for immune checkpoint inhibitor therapy.
Authors
- Zenghua Deng
- Nan Luo (ORCID: https://orcid.org/0000-0001-7980-6979)
- Chen Li (ORCID: https://orcid.org/0000-0002-8438-259X)
- Xiang Li (ORCID: https://orcid.org/0000-0002-1610-6155)
- Jianfei Chen (ORCID: https://orcid.org/0000-0001-6575-4493)
- Wenxia Li (ORCID: https://orcid.org/0009-0009-5223-2341)
- Dongfang Liu (ORCID: https://orcid.org/0000-0002-7295-8088)
- Jirun Peng
- Wenzhe Hu
- Zichao Qiu
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fmed.2024.1403171
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- National Natural Science Foundation of China